Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
2024 · New England Journal of Medicine · 132 citations
https://doi.org/10.1056/nejmoa2401726
A
Abhishek Tripathi
ITM University(IN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
1.6K
Citations
20
h-index
38
i10-index
Abhishek Tripathi is an academic researcher from ITM University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Cancer Immunotherapy and Biomarkers & Renal cell carcinoma treatment. The author has an h-index of 20, co-authored 151 publications.
ORCID: 0000-0002-5198-0673Papers by this author
worksValorization of used cooking oil: challenges, current developments, life cycle assessment and future prospects
2025 · Discover Sustainability · 45 citations
https://doi.org/10.1007/s43621-025-00905-7
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma
2024 · Journal of Clinical Oncology · 33 citations
https://doi.org/10.1200/jco.24.00767
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer
2021 · Prostate Cancer and Prostatic Diseases · 29 citations
https://doi.org/10.1038/s41391-021-00433-1
PARP inhibitors in castration-resistant prostate cancer
2020 · Cancer Treatment and Research Communications · 16 citations
https://doi.org/10.1016/j.ctarc.2020.100199
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration
2024 · Prostate Cancer and Prostatic Diseases · 9 citations
https://doi.org/10.1038/s41391-024-00805-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat